These results, together with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,two assist the concept of targeting ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-related Problems. Will help to lower Continual discomfort https://henryl444njd4.bloggactif.com/profile